CAD 0.58
(-8.0%)
Year | Eps | Eps Growth |
---|---|---|
2023 | -0.07 CAD | 27.49% |
2022 | -0.10 CAD | 0.1% |
2021 | -0.10 CAD | -498.8% |
2020 | -0.02 CAD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q2 | -0.01 CAD | -15.93% |
2024 Q1 | -0.01 CAD | -7.62% |
2023 Q1 | -0.02 CAD | 24.62% |
2023 Q3 | -0.02 CAD | 26.05% |
2023 Q2 | -0.02 CAD | 12.24% |
2023 FY | - CAD | 27.49% |
2023 Q4 | -0.01 CAD | 33.96% |
2022 Q3 | -0.02 CAD | 42.15% |
2022 Q1 | -0.01 CAD | 40.93% |
2022 FY | - CAD | 0.1% |
2022 Q2 | -0.03 CAD | -145.71% |
2022 Q4 | -0.03 CAD | -63.32% |
2021 Q1 | -0.02 CAD | 11.28% |
2021 FY | - CAD | -498.8% |
2021 Q2 | -0.02 CAD | 33.33% |
2021 Q4 | -0.02 CAD | 21.0% |
2021 Q3 | -0.03 CAD | -97.37% |
2020 Q2 | -0.00 CAD | 0.0% |
2020 Q4 | -0.03 CAD | -414.0% |
2020 FY | - CAD | 0.0% |
2020 Q3 | -0.01 CAD | -212.5% |
Name | Eps | Eps Difference |
---|---|---|
Algernon Pharmaceuticals Inc. | -0.45 CAD | 84.0% |
Asep Medical Holdings Inc | -0.13 CAD | 44.615% |
BetterLife Pharma Inc. | -0.03 CAD | -172.727% |
BioVaxys Technology Corp. | -0.06 CAD | -25.654% |
ChitogenX Inc. | -0.02 CAD | -238.028% |
Rapid Dose Therapeutics Corp. | -0.04 CAD | -75.61% |
Defence Therapeutics Inc. | -0.30 CAD | 76.0% |
Entheon Biomedical Corp. | -0.05 CAD | -41.732% |
Glow Lifetech Corp. | -0.03 CAD | -150.0% |
Lexston Life Sciences Corp. | -0.02 CAD | -213.043% |
Pharmala Biotech Holdings Inc. | -0.01 CAD | -682.609% |
Doseology Sciences Inc. | -0.08 CAD | 9.661% |
MYND Life Sciences Inc. | -0.03 CAD | -124.299% |
Nova Mentis Life Science Corp. | -0.01 CAD | -767.47% |
PharmaTher Holdings Ltd. | -0.04 CAD | -103.966% |
PreveCeutical Medical Inc. | -0.00 CAD | -2900.0% |
Telescope Innovations Corp. | -0.12 CAD | 40.0% |